Developer of an on-demand personalized implant manufacturing infrastructure with a full scope of related services, including all steps of the implant-printing process from 3D-modeling to receiving a sterilized personalized device, ready for implantation.
You had one choice and it was titanium. Yes, it saved many lives. But titanium people faced problems: in the cold, the feeling of ice inside the body, when the heat, then you seemed to be split on fire, any change in the weather was discomfort, and other life risks might appear such as thrombosis and rejection. Imagine that you have a choice, not a titanium , but your own bone. fiction. no, it's reality that came today
Rcently the global healthcare system problems have become strikingly evident. The COVID-19 outbreak has exacerbated existing issues in the industry, causing many professionals to rethink the healthcare models currently in place. Breakthrough improvements regarding treatment could surely result from big data and AI applications; however, the basic demand for materials (such as human tissue and organs), remains largely unmet due to supply chain vulnerabilities.
With the adoption of 3D printing in the healthcare industry, many of these problems could be drastically improved through cost reduction and time saving.
Patients may upload and securely store their MRI and CAT scans on the digital platform. Should the patient be in need of the bone implant, certified clinicians would be able to use the platform to create a 3D model of the implant based directly on the patient's medical data.
Overall production time will take up to 24 hours, which is substantially faster compared to the existing alternatives. At the same time, use of 3D-printing technology and AIBY material composites results in a lower cost of production than for titanium or PEEK-based implants.
AIBY will help medical professionals through a developed set of Quality Management System procedures, which will ensure safety, efficacy and quality of the implant. Medical professionals will receive a sterilized 3D-printed bone implant ready for use in surgery.
AIBY bone implants are biodegradable. They stimulate osteogenesis and are fully replaced by the bone tissue over time. Therefore, there is no need for reoperation to extract metal fixation elements.
Rcently the global healthcare system problems have become strikingly evident. The COVID-19 outbreak has exacerbated existing issues in the industry, causing many professionals to rethink the healthcare models currently in place. Breakthrough improvements regarding treatment could surely result from big data and AI applications; however, the basic demand for materials (such as human tissue and organs), remains largely unmet due to supply chain vulnerabilities
Hydroxyapatite (HA) is a component of biologically hard tissues, including tooth enamel. The small HA crystal (mcGA) shows a stronger uptake of any streptococci than the medium-sized crystal (srcGA) and large crystal (bcGA). We investigated the potential effectiveness of mcGA as an agent for removing streptococci from the oral cavity in a dental drug delivery system (3DS) using a fixative drug that can fit on an individual tooth. First, the simulated absorption of srcGA and bcGA by heating at 800 and 1200 degrees Celsius, respectively, and two types of mcGA by heating at 0 and 200 degrees Celsius, respectively, were studied in human saliva. Then we conducted clinical trials of 3DS using mcGA paste on 5 people. Method: in artificial (1) Streptococcus mutans was mixed with HA or HA coated with saliva (c-HA) in a phosphate - salt buffer solution with and without the addition of bivalent metal ions Ca2+ and Mg2+, respectively, and was kept for 90 minutes at 37 degrees Celsius.
After the mixture stood at room temperature, the optical density of the supernatants (O. D. 550) was analyzed to assess the level of bacterial uptake. in natural conditions: (2) 3DS using paste was used daily for 5 minutes for 1 week.
The number of oral bacteria was quantified by seeding the induced saliva obtained during and after a week of use. Results: The bacterial uptake of mcGA decreased by Ca2+ depending on the dose, while Mg2+ showed no effect on uptake. From this, it can be concluded that Ca2+ in saliva can disrupt the absorption of bacteria by the paste with mcGA in the oral cavity. Clinical saliva studies showed that after 5 weeks of using 3DS mutans, streptococci was removed from the oral cavity using 3DS with a paste containing mcGA. Conclusions: paste with scGA is an effective substance for removing mutans streptococci from the oral cavity in 3DS, especially if a fixation system is used that eliminates the impact of saliva.
We are constantly looking for people who are as excited as we are to develop the platform that aims to disrupt outdated healthcare models.
Let us know if you are one of us!